Anocca doses first patients with precision TCR‑T therapy
11th June 2026 Uncategorised 0
Company begins phase 1 treatment in multi‑centre VIDAR‑1 trial

More: Anocca doses first patients with precision TCR‑T therapy
Source: News
Company begins phase 1 treatment in multi‑centre VIDAR‑1 trial

More: Anocca doses first patients with precision TCR‑T therapy
Source: News
© 1994 - 2026 B.M. Pharmaceuticals